Kiora Pharmaceuticals Inc. (KPRX)
NASDAQ · Healthcare
Kiora Pharmaceuticals Inc. Operating Income 2015–2025
Kiora Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2018 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Kiora Pharmaceuticals Inc. operating income for the quarter ending September 30, 2025 was -794437, a 77.95% decrease year-over-year.
- Kiora Pharmaceuticals Inc. operating income for the twelve months ending September 30, 2025 was -9.1 M, a 529.20% decrease year-over-year.
- Kiora Pharmaceuticals Inc. annual operating income for 2025 was -12.8 M, a 384.48% decrease from 2024.
- Kiora Pharmaceuticals Inc. annual operating income for 2024 was 4.5 M, a 135.83% decrease from 2023.
- Kiora Pharmaceuticals Inc. annual operating income for 2023 was -12.6 M, a 11.58% decrease from 2021.
- Kiora Pharmaceuticals Inc. annual operating income for 2021 was -14.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kiora Pharmaceuticals Inc. Operating Income — FAQ
Kiora Pharmaceuticals Inc. (KPRX) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Kiora Pharmaceuticals Inc.'s operating income?
Kiora Pharmaceuticals Inc. (KPRX) reported operating income of -$13M for fiscal 2025.
Where can I see KPRX's operating income history?
The chart and table above show Kiora Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.